426 related articles for article (PubMed ID: 8341998)
41. Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy.
Int J Tuberc Lung Dis; 2001 Jan; 5(1):40-5. PubMed ID: 11263515
[TBL] [Abstract][Full Text] [Related]
42. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
[TBL] [Abstract][Full Text] [Related]
43. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
Moulding TS; Le HQ; Rikleen D; Davidson P
Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
[TBL] [Abstract][Full Text] [Related]
44. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
45. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Danckwerts MP; Ebrahim S; Pillay V
Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
[TBL] [Abstract][Full Text] [Related]
46. [Our experience in short-course treatment of tuberculosis. Results obtained by using therapeutic regimens of 6 to 8 months].
Ben Kheder A; Chabbou A; Zakhama B; Zaimi M; el Gharbi T; el Mekki L; el Gharbi B
Bull Int Union Tuberc; 1985; 60(1-2):26-8. PubMed ID: 4074968
[No Abstract] [Full Text] [Related]
47. Three-in-one TB drug approved.
Posit Aware; 1995; ():5. PubMed ID: 11362378
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy of unfixed continuation phase short-course chemotherapy].
Xiao C; Fu Y; Li Z
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447
[TBL] [Abstract][Full Text] [Related]
49. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
Kawakami K
Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
[TBL] [Abstract][Full Text] [Related]
50. [Antitubercular chemotherapy].
Jouveshomme S; Dautzenberg B
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
[TBL] [Abstract][Full Text] [Related]
51. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
52. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
53. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
[TBL] [Abstract][Full Text] [Related]
54. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
55. [Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project].
Magdorf K; Arizzi-Rusche AF; Geiter LJ; O'Brien RJ; Wahn U
Pneumologie; 1994 Oct; 48(10):761-4. PubMed ID: 7808991
[TBL] [Abstract][Full Text] [Related]
56. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
Cowie RL; Brink BA
S Afr Med J; 1990 Apr; 77(8):390-1. PubMed ID: 2184527
[TBL] [Abstract][Full Text] [Related]
57. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
[TBL] [Abstract][Full Text] [Related]
58. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
Lambert LA; Ijaz K; Navin TR
Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
[No Abstract] [Full Text] [Related]
59. [Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
Brändli O; Häcki MA; Scheel A; Stiefel M
Schweiz Med Wochenschr; 1983 Jan; 113(3):92-6. PubMed ID: 6828844
[TBL] [Abstract][Full Text] [Related]
60. [Short-term chemotherapy of tuberculosis. Cooperative French trial].
Pretet S
Rev Fr Mal Respir; 1983; 11(6):859-66. PubMed ID: 6366945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
